Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.
In this study we examined the megakaryocyte genome in 12 patients with MPNs to determine whether there are somatic variants and whether there is any association with marrow fibrosis. We performed targeted next-generation sequencing for 120 genes associated with myeloid neoplasms on megakaryocytes isolated from aspirated bone marrow. Eleven of the 12 patients had genomic defects in megakaryocytes that were not present in nonmegakaryocytic hemopoietic marrow cells from the same patient. The greatest allelic burden was in patients with increased reticulin deposition. The megakaryocyte-unique mutations were predominantly in genes that regulate chromatin remodeling, chromosome alignment, and stability. These findings show that genomic abnormalities are present in megakaryocytes in MPNs and that these appear to be associated with progression to bone marrow fibrosis.
PMID: 28502479 [PubMed - as supplied by publisher]
Source: The American Journal of Pathology - Category: Pathology Authors: Guo BB, Nigel Allcock RJ, Mirzai B, Jacobus Malherbe JA, Choudry FA, Frontini M, Chuah H, Liang J, Kavanagh SE, Howman R, Ouwehand WH, Fuller KA, Erber WN Tags: Am J Pathol Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Genetics | Leukemia | Myeloproliferative Disorders | Pathology | Stem Cell Therapy | Stem Cells | Study